You are here: Industry Insights > Market News > Health Tip: Treating a Bunion

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

3-Bromo-4-fluorobenzaldehyde

5-Methyl-1,3,4-oxadiazol2(3H)-one

4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride

4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine

3-Pyridinecarboxaldehyde

Ethyl 3 Fluorobenzoate

Health Tip: Treating a Bunion

drugsJuly 15, 2019

Tag: toe , bunion , health

Favorites

A bunion is a bone-like bump that forms at the base of the big toe, says Mayo Clinic.

It may form when the big toe pushes against the next toe, forcing the joint of the big toe to stick out.

Mayo Clinic mentions treatment options for bunions:

Changing shoes.
Using padding, tape or a splint.
Applying ice.
Using shoe inserts.
Taking medication.

If non-surgical treatment doesn't provide relief, surgery may be required.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content,

please email: Julia.Zhang@ubmsinoexpo.com

Previous:Health Tip: Causes of Dry Eye

Next:Urgent Sourcing Needs of【En-CPhI.cn】2019.07.15

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

BioPharmaSpec, the leading global Contract Research Organization (CRO) for Discovery and Preclinical Characterization of Biopharmaceuticals, has officially announced three new European facilities.

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Health Tip: Treating a Bunion | Pharmasources.com

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

PharmaSourcesNovember 15, 2024

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may like
More>>

Pet Plastic Amber Solid Pill Bottle Healthcare Supplement Container Withscrew Cap 250ml

SGGZ type health wine filling and sealing machine

Health care product Camptothecin 10-Hydroxy camptothecin , 7-ethyl-10-hydroxy-camptothecin

Natura beta-Carotene HPLC 10% -98% CAS 7235-40-7 Food Grade for Health Food

Health Care Routine Flavonoids Fagopyrum Tataricum Suppliers Rutin Tartary Buckwheat Extract

Wellgreen Factory Direct Export Food Grade Health Care Use Fennel Seeds Extract Powder

Resistant Dextrin Powder (Corn) Dextrin CAS 9004-53-9 Food Grade for Health Food

Pet Plastic Amber Solid Pill Bottle Healthcare Supplement Container Withscrew Cap 75ml

Antarctic Krill Oil anti-aging healthsupplement

PZ COLLOCATION TANK CONCENTRATED -COLLOCATION TANK DILUTER COLLOCATION TANK TOMATOES MANGO JUICE CON

Health Tip: Treating a Bunion

Related News

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

InnoCare Announces First Subject Dosed in the Phase III Registrational Trial of TYK2 Inhibitor ICP-332 for the Treatment of Atopic Dermatitis in China

You may likeMore>>

You may like
More>>